Skip NavigationSkip to Content
Return Return to Search Results

Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients

  1. Author:
    Epling, Brian P [ORCID]
    Powers,John

  2. Author Address

    Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Clinical Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.,
    1. Year: 2022
    2. Date: Jul 18
    3. Epub Date: 2022 07 18
  2. Journal: Antimicrobial Agents and Chemotherapy
    1. Pages: e0076622
  4. Type of Article: Letter
  5. Article Number: e0076622
  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1128/aac.00766-22
  3. PMID: 35862749

Library Notes

  1. Fiscal Year: FY2021-2022
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel